Insider trade

Director sold ~$224K of CME shares in the open market

Traded Feb 6, 2026 · Filed Feb 9, 2026

CME GroupCME

~$224K
Reported value · 748 sh @ $300.00: 2,699
Holds after · shares reported: -12.3%
stock since the trade · S&P 500 +10.6%, $302.27 → $265.10 on Oct 1

Why it stands out

A board member of CME Group sold $224K of CME Group shares. Nobody planned it ahead of time.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Feb 6, 2026
Reporting period: Not applicable
Filed with the SEC: Feb 9, 2026

Director$100K–$500K

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$224,400

Shares × reported transaction price

Timing vs results

2 days after results of Feb 4, 2026, 75 days before results of Apr 22, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $302.27 on Feb 6, 2026, at its 52-week high, after a 10% rise over the previous 30 trading days

52-week range $241.74 (Feb 11, 2025) to $302.27 (Feb 6, 2026), 100% of the way up, from 251 adjusted closes. 30 trading days earlier: $275.53 on Dec 23, 2025. Describes the past only, not a forecast

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

Securities lawsuit open at the trade date

A securities lawsuit naming the company as a defendant was filed on Jun 14, 2024 in the U.S. District Court, S.D. New York. A filing is an allegation, not a finding.

Global Carbon Opportunity (Cayman) Fund Ltd. v. CME Group Inc., docket 1:24-cv-04562, via CourtListener (court records). Nature of suit 850, company named as first defendant

After it was reported

After	Stock	S&P 500	Difference
7 days	-1.1%	-1.3%	+0.2%
30 days	+1.4%	-3.8%	+5.2%
90 days	-7.9%	+6.8%	-14.7%
180 days	-14.1%	+11.7%	-25.7%

Past results only. Not a forecast.

Source receipt

Record ID: 0001628280-26-006282
Filed / recorded: Feb 9, 2026, 6:03 PM UTC
Added to OQRO: Oct 2, 2026, 12:27 PM UTC
Parser: form4-xml-v1
Data quality: Verified: identifiers matched exactly
Issuer: CME GROUP INC.
Issuer CIK: 1156375
Ticker: CME
Reporting person: Dennis Suskind
Relationship: Director
Security: Common Stock Class A
Table: Non-derivative (Table I)
Transaction date: Feb 6, 2026
Transaction code: S
Shares / units: 748
Price per share: $300.00
Acquired / disposed: Disposed (D)
Shares owned after: 2,699
Ownership form: Direct
Amendment: No

Around the same time

Director sold7mo ago

~$320KReported value · 1,000 sh @ $320.00

A board member of CME Group sold $320K of CME Group shares. Nobody planned it ahead of time.

Why it stands out Official record

Director sold8mo ago

~$1.3MReported value · 4,200 sh @ $309.65

A board member of CME Group sold $1.3M of CME Group shares. Nobody planned it ahead of time.

Why it stands out Official record

Director sold8mo ago

~$92KReported value · 300 sh @ $305.90

A board member of CME Group sold $92K of CME Group shares. Nobody planned it ahead of time.

Why it stands out Official record